Lyell Immunopharma, Inc.
Price Action
Technical Summary
WEAKENINGLyell Immunopharma, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 7), showing significant lag compared to the market leaders. Earnings contraction of 5% provides fundamental context to the price action. Investors should exercise caution due to high volatility (82% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $13.04 | -2.22% | BELOW |
| 50 SMA | $17.15 | -25.68% | BELOW |
| 100 SMA | $19.87 | -35.83% | BELOW |
| 150 SMA | $22.31 | -42.85% | BELOW |
| 200 SMA | $20.77 | -38.61% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LYEL in an uptrend right now?
LYEL has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is LYEL overbought or oversold?
LYEL's RSI (14) is 33. The stock is in neutral territory, neither overbought nor oversold.
Is LYEL outperforming the market?
LYEL has a Relative Strength (RS) Rating of 7 out of 99. LYEL is currently lagging the broader market.
Where is LYEL in its 52-week range?
LYEL is trading at $12.75, which is 28% of its 52-week high ($45.00) and 11% above its 52-week low ($8.63).
How volatile is LYEL?
LYEL has a Beta of 1.88 and 52-week volatility of 82%. It's more volatile than the S&P 500 - expect bigger swings.